Futbolcularda Peroksizom Proliferatör – Aktive Reseptör Alfa rs4253778 Polimorfizm Dağılımının Belirlenmesi

Year 2018, Volume: 3 Issue: 2, 75 - 79, 27.12.2018

Didem Akçamlı Selen Sipahi İpek Yüksel Nazlı Can Kavas Tolga Polat Canan Sercan Sezgin Kapıcı Başak Funda Eken Korkut Ulucan

Abstract

İnsan genom projesinden sonra toplam sayısının 20-25 bin olduğu düşünülen genlerimizden yaklaşık

olarak 250’si atletik performans ile ilişkili olduğu tahmin edilmektedir. Bu gen bölgelerinden dayanıklılık

performansına etki edenlerden biri de peroksizom – proliferatör aktive reseptör alfa (PPARA) rs4253778

polimorfizmidir. Çalışmamızda genç futbolcularda PPARA rs4253778 polimorfizminin dağılımlarını

belirlemeyi amaçladık. Çalışmamıza 64 genç Türk futbolcu katılmıştır. Futbolculardan DNA örnekleri, ağız

içi epitel hücrelerden ticari DNA izolasyon kiti kullanılarak elde edilmiştir. Genotiplendirme işlemi, gerçek

zamanlı polimeraz zincir reaksiyonu (PZR) tekniği ile gerçekleştirilmiştir. Çalışmaya katılan futbolculardan

42’si GG, 21’i GC ve bir futbolcuda CC genotipinde olduğu saptanmıtır. G alleli 105, C alleli ise 23 olarakbelirlenmiştir. Kohortumuzda, patlayıcı güç fenotipi ile ilişkili olan PPARA GG genotipi ve G allelinin

daha baskın olduğu görülmüştür. Futbolcular üzerinde gerçekleştirilen bu pilot çalışmanın bundan sonra

yapılacak olan daha yüksek verili çalışmalara ışık tutacağı inancındayız.

Keywords

Futbol, Spor genetiği, Polimorfizm, PPARA

Determination of Peroxisome Proliferator – Activated Receptor Alpha rs4253778 Polymorphism in Football Players

Abstract

Approximately 250 regions of our genes, estimated to the total of 20-25 thousand genes, as a rusult of

Human Genome Project, have been associated with athletic performance. One of these gene regions

that affects endurance performance is the peroxisome – activated receptor alpha (PPARA) rs4253778

polymorphism. We aimed to determine the distribution of PPAR polymorphism in young football players.

64 young Turkish football olayers were enrolled to the study. NA isolations were obtained from buccal cells

by using commercial DNA isolation kit. Genotyping is carried out by real-time PCR technique. As a result,

42 of the players were found as GG, 21 players as GC and 1 player as CC genotypes. G allele was counted as

105 and C allele as 23. In our cohort, PPARA GG genotype and G allele, which are associated with power

phenotype, were found to be more dominant. We believe that this pilot study among footballers will guide

for further studies with an extended number of subjects.

Keywords

Football, Sports genetics, Polymorphism, PPARA

References

• Ahmetov, I.I., Mozhayskaya, I.A., Flavell D.M., Astratenkova I.V., Komkova A.I., ve ark. (2006). PPARalpha gene variation and physical performance in Russian athletes. Eur J Appl Physiol, 97, 103–108.
• Corak, A., Kapıcı, S., Sercan, C., Akkoç, O. ve Ulucan, K. (2017). A pilot study for determination of anxiety related SLC6A4 promoter “S” and “L” alleles in healthy Turkish athletes. Cellular and Molecular Biology, 63(5), 29-31.
• Braissant, O., Foufelle, F., Scotto, C., Dauca, M. ve Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, – beta, and – gamma in the adult rat. Endocrinology, 137, 354–366.
• Cabrero, A., Laguna, J.C. ve Vazquez, M. (2002). Peroxisome proliferator-activated receptors and the control of inflammation. Curr Drug Targets, 1, 243–248.
• Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J., ve ark. (2002). Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet, 360, 1410–1418.
• Eynon, N., Meckel, Y., Sagiv, M., Yamin, C., Amir, R. ve ark. (2010). Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scand J Med Sci Sports, 20, e145–150.
• Ginevičienė, V., Pranckevičiene, E., Milasˇius, K., ve Kučinskas, V. (2010). Relating fitness phenotypes to genotypes in Lithuanian elite athletes. Acta Medica Lituanica, 17, 1–10.
• Jamshidi, Y., Montgomery, H.E., Hense, H.W., Myerson, S.G., Torra, I.P., ve ark. (2002). Peroxisome proliferator–activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation, 105, 950–955.
• Leone, T.C., Weinheimer, C.J. ve Kelly, D.P. (1999): A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA, 96, 7473–7478.
• Maciejewska, A., Sawczuk, M. ve Cięszczyk, P. (2011). Variation in the PPARα gene in Polish rowers. Journal of Science and Medicine in Sport, 14(1), 58-64.
• Pyper, S.R., Viswakarma, N., Yu, S. ve Reddy, J.K. (2010). PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal, 8, e002.
• Santos, C.G., Pimentel-Coelho, P.M. Budowle, B., de Moura-Neto, R.S., Dornelas-Ribeiro, M., Pompeu, F.A. ve Silva, R. (2015). The heritable path of human physical performance: from single polymorphisms to the “next generation”. Scandinavian Journal of Medicine and Science in Sports, 26(6), 600-612.
• Šeda, O. ve Šedová, L. (2007). Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and type 2 diabetes. Pharmacogenomics, 8, 587–596.
• Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M. ve ark. (1998). Activation of human aortic smoothmuscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature, 393, 790–793.
• Ulucan, K,, Göle, S., Altindas, N., Güney, A.I. (2013): Preliminary findings of alphaactinin-3 gene distribution in Turkish elite wind surfers. Balkan journal of medical genetics, 16(1), 69 – 72.
• Ulucan, K., Yalçın, S., Akbaş, B., Konuk, M. (2014): Genç Türk basketbol oyuncularında SLC6A4 promotör polimorfizminin analizi. The Journal of Neurobehavioral Sciences, 1(2), 37-40.